D-0583-2024 Class II Terminated
FDA drug recall D-0583-2024 was initiated by Dr. Reddy's Laboratories, Inc. on June 7, 2024 and is designated Class II. Reason for recall: Presence of foreign substance. The recall status is terminated (terminated December 22, 2025). Affected quantity: 20,520 units.
Recall Details
- Product Type
- Drugs
- Report Date
- July 10, 2024
- Initiation Date
- June 7, 2024
- Termination Date
- December 22, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 20,520 units
Product Description
Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106 USA, NDC 55111-730-01.
Reason for Recall
Presence of foreign substance.
Distribution Pattern
IL, MS, OH
Code Information
L2300594